A biological-age or epigenetic-clock test reports a number meant to describe how old your body looks at the molecular level, and that number often does not match the age on your birth certificate. It is worth being clear at the outset about what the result is: a statistical estimate built from chemical marks on your DNA, useful for studying aging across large populations, but far too noisy to serve as a personal readout of how long any one person will live. Research supported by the National Institute on Aging shows these estimates can predict health outcomes and mortality in groups of older adults. The leap from that group finding to your individual score is where most of the confusion, and most of the marketing, lives.
Key points#
- The test reads DNA methylation, a pattern of chemical tags on the genome that changes with age, and a model turns those readings into an age estimate.
- Different clocks answer different questions: some predict your calendar age, some predict disease and death, and one estimates the rate at which you are aging.
- Across populations the signal is real; for a single person, repeat tests can disagree by years, which is within the noise of the assay.
- The habits that actually protect healthy aging (activity, sleep, not smoking, diet, social ties, managing chronic conditions) do not depend on any clock reading.
Reading the number backward: what it is not#
It helps to start with what a biological-age result is not, because that clears away the most common misreadings. It is not a measurement in the sense that a blood glucose or blood pressure value is a measurement. There is no physical ruler for biological age. The figure you receive is a prediction produced by a model that was trained to find whichever methylation patterns best lined up with age, or with illness and death, in the particular population it studied. Two features follow from that. First, the output carries the statistical assumptions of the clock, not just your biology. Second, because it is a model estimate rather than a direct reading, the same DNA can yield different answers depending on which clock ran the calculation.
The chemistry the test is reading#
Underneath the number is DNA methylation. Small methyl groups attach to specific positions on the genome, at locations called CpG sites, and which sites carry those tags shifts in fairly orderly ways as people age. A biological-age test measures methylation across hundreds to thousands of these sites from a blood or saliva sample and feeds the readings into its model. You can picture the genome as a long control panel of switches: aging does not flip them at random but nudges a recognizable subset in a recognizable direction, and the clock is trained to recognize that drift.
Why two tests can disagree: generations of clocks#
Much of the apparent contradiction between products comes from the fact that they are not asking the same question.
First-generation clocks, such as the original Horvath and Hannum clocks, were trained to predict chronological age. They estimate how many years old a group of people is with real accuracy, but guessing a birthday you already know is not the same as forecasting health.
Second-generation clocks, including PhenoAge and GrimAge, were trained against health measures and mortality rather than the calendar. They tend to line up more closely with disease risk and death, which is why they attract the most clinical interest.
A pace-of-aging measure, DunedinPACE, does something different again. As its founding paper describes, it was built by tracking the decline of multiple organ systems across roughly two decades in the Dunedin birth cohort in New Zealand, and it estimates the rate at which a person is aging rather than assigning a single age. A rate and a snapshot are not interchangeable, so a product that reports one should not be read as though it reported the other.
What the evidence supports, and what it does not#
At the population level the signal holds up. The NIA-funded work found that epigenetic clocks can predict age-related outcomes, including multimorbidity and mortality. That same study also supplies the caution that should anchor any honest reading: demographic, socioeconomic, mental-health, and behavioral factors were comparable to, and often stronger than, epigenetic age acceleration as predictors of late-life health. Epigenetic measures tracked with concurrent cognitive difficulty and functional limitation, yet social and behavioral factors generally predicted those outcomes at least as well, with multimorbidity the one place the epigenetic signal clearly earned its keep.
The distance between group accuracy and individual reliability is the heart of the matter. A published appraisal of epigenetic clocks as personal biomarkers sets out why a single score is fragile. Running the same sample twice has produced age estimates that differ by several years, so a one-year or two-year change between your own tests can sit entirely within measurement error. Methylation itself moves on the scale of minutes to hours and responds to diet, stress, and sleep, which means one timepoint can capture a passing state rather than durable biology. Clocks trained on blood can be off by decades when applied to other tissues. And there are no agreed cut-off values, no consensus reference standard, and no settled definition of what biological age even is. The same appraisal concludes that these tools do not meet standard criteria for clinical utility and that using them to guide an individual's decisions may be uninformative.
How to hold your own result#
The steady way to read a biological-age result is as one data point with wide uncertainty, not a diagnosis. A number a few years off your chronological age is often just the noise of the assay talking. Because these clocks partly register the biological imprint of hardship, poverty, and chronic stress, an elevated result can reflect the circumstances a person has lived through rather than any personal failing, and treating the score as a private health grade misreads the cause.
The interventions with the strongest evidence for healthy aging do not come from a clock at all. As the National Institute on Aging summarizes, the durable levers are physical activity, not smoking, a nutritious diet, managing chronic conditions, staying socially connected, and sleep. None of those require a methylation test to justify, and none should be started or stopped on the strength of one number.
Biological-age testing is a legitimate and fast-moving research instrument. Whether it matures into a dependable clinical tool for individuals will turn on standardization, reproducibility, and validation that the current generation has not yet reached. Until it does, the sensible posture is interest without conviction: a field genuinely worth watching, not a scoreboard for your life.
Sources and further reading
Questions and answers
If my epigenetic age is higher than my real age, should I worry?
Not on the basis of one test. Repeat measurements of the same sample can differ by several years, so a modest gap often falls inside the margin of error. A result is a prompt to look at the ordinary drivers of health, not a diagnosis in itself.
Can lowering my biological age add years to my life?
No study has shown that nudging a clock reading changes how long an individual lives. The clocks are trained to correlate with outcomes in populations, which is not the same as being a dial you can turn to buy time. The evidence-backed levers remain the everyday habits, not the number.
Why do two biological-age tests give me different answers?
Because they are often built to predict different things (calendar age, disease and death, or the rate of aging) and were trained on different populations. Add normal assay noise and day-to-day shifts in methylation, and two products can reasonably disagree.